Segal Trials

Posts by:

Segal Trials

Understanding Anxiety Better: Continuing the Conversation from Last Year's Discussion

Welcome to Part 2 of our exploration into anxiety. Last year, we discussed common behaviors and symptoms associated with Social Anxiety Disorder in our blog: If you can relate, you may have social anxiety disorder. Today, we delve deeper, offering new insights and the latest information to help you understand this pervasive condition. If you find yourself relating to these experiences, it may be time to consider professional avenues, including potential participation in a clinical trial for anxiety.

Read More

Segal Trials Recognized for Exceptional Enrollment in Landmark Schizophrenia Study

Miami Lakes, FL – Segal Trials, a leading clinical research organization specializing in acute schizophrenia trials, has been recognized by the PPD Select Global Partnership Program for outstanding enrollment performance. This accolade was awarded for the site’s exemplary participation in the Phase 2 study of CVL-231 (Emraclidine), aimed at treating patients experiencing an acute exacerbation of psychosis.

Read More

Segal Trials and Cook MyoSite Achieve Groundbreaking Milestone with Nation’s First Injection of Iltamiocel in Women Suffering from Chronic Fecal Incontinence in the DigniFI Study

[North Miami, FL – [August 21, 2024] – Segal Trials is proud to announce the completion of the first injection procedure in the DigniFI Study. The Women’s Health Team, under the leadership of Principal Investigator Steven Chavoustie, M.D., FACOG and Sub-Investigator Brittany Berre MSN, ARNP, FNP-C, worked diligently to prepare for this vital women's health study. The study's first injection procedure was performed on August 19, 2024.. Segal Trials also completed the first muscle tissue procurement procedure for the study on March 21, 2024.

Read More

The Critical Role of Women's Health Studies in Advancing Personalized Medicine

In the field of medical research, the study of women's health is essential, illuminating unique health needs and leading the way in personalized medicine. Historically, much of medical research has focused on male subjects, leaving gaps in our understanding of female-specific health issues. As we advance in healthcare, the focused study of women’s health and sex differences not only improves our understanding but also drives innovations that promise better health outcomes for everyone. This article explores the significant impact of female-centric clinical studies and highlights the efforts of institutions like Segal Trials to address these critical areas.

Read More

Bridging the Diversity Gap in Clinical Trials: Our Ongoing Mission

In the evolving landscape of medical research, the inclusion of diverse populations in clinical trials is critical. Each individual's unique genetic background and lifestyle factors significantly influence both the efficacy and safety of new medications. Historically, the lack of diversity in clinical trials has been a glaring issue, with significant repercussions. It has not only failed to address the needs of all populations but has also stifled innovation, costing the pharmaceutical industry billions, as highlighted in recent studies.

Read More
Rishi Kakar, MD from Segal Trials

New Video Alert: Promising Developments in Schizophrenia Treatment with Dr. Kakar

🎥 New Video Alert: Promising Developments in Schizophrenia Treatment with Dr. Kakar

In our continued commitment to long-term schizophrenia research, Segal Trials is excited to share an exclusive video interview with Dr. Kakar, our esteemed CSO and Medical Director at Segal Trials. As a lead investigator for the groundbreaking study on KarXT, he explains the latest data collected, and how it's showing promise for the treatment of schizophrenia.

Read More
Postpartum depression clinical study

Exploring New Frontiers in Postpartum Depression Treatment: A Look at Psychedelics and Ongoing Clinical Studies

Postpartum depression (PPD) continues to be a significant challenge affecting many new mothers, altering the joyous occasion of childbirth into a time of struggle and emotional turmoil. With advances in medical research, new treatment avenues are opening up, offering hope where traditional methods might fall short. One such promising field is the use of psychedelics in treating mood disorders like PPD.

Read More

Workplace Strategies to Handle Toxicity & Promote Mental Health

Welcome to the brighter side of corporate culture, where we not only navigate the choppy waters of workplace dynamics but also offer a lifeline to those struggling with mental health issues like generalized anxiety disorder, social anxiety disorder, and depression. Today, we'll delve into managing challenging personalities at work and how Segal Trials, a clinical trials company, provides alternative care options to help you thrive both professionally and personally.

Read More
Segal Trials are leaders in Psychedelics Research

The Psychedelic Renaissance: A Leap Forward in Mental Health Treatment

In the wake of the COVID-19 pandemic, humanity has been ushered into what many might call a "new normal," a period marked by profound shifts in our way of life and, notably, in our collective mental health. The psychological aftermath of the pandemic, compounded by other life-altering events, has spotlighted an undeniable crisis: a dramatic surge in mental health issues, burdening an already overwhelmed and antiquated mental health treatment system. Traditional treatments for conditions like addiction, anxiety, depression, and PTSD have remained largely unchanged for decades, sparking a crucial conversation about the need for innovation in mental health care.

Read More